| 000 | 01704 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512174853.0 | ||
| 264 | 0 | _c19690520 | |
| 008 | 196905s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/0014-2999(68)90152-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMolinengo, L | |
| 245 | 0 | 0 |
_aOn the pharmacological inhibition of epinephrine-induced ventricular automaticity. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cDec 1968 |
||
| 300 |
_a23-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcetanilides _xpharmacology |
| 650 | 0 | 4 |
_aAcetylcholine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAtropine _xpharmacology |
| 650 | 0 | 4 |
_aBenzoates _xpharmacology |
| 650 | 0 | 4 |
_aEmetine _xpharmacology |
| 650 | 0 | 4 |
_aEphedrine _xpharmacology |
| 650 | 0 | 4 |
_aEpinephrine _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 |
_aHeart Ventricles _xdrug effects |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethanol _xpharmacology |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Smooth _xdrug effects |
| 650 | 0 | 4 |
_aProcainamide _xpharmacology |
| 650 | 0 | 4 |
_aQuinacrine _xpharmacology |
| 650 | 0 | 4 |
_aQuinidine _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSecologanin Tryptamine Alkaloids _xpharmacology |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 |
_aSympatholytics _xpharmacology |
| 650 | 0 | 4 |
_aUrethane _xpharmacology |
| 650 | 0 | 4 |
_aVentricular Fibrillation _xdrug therapy |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 5 _gno. 1 _gp. 23-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0014-2999(68)90152-0 _zAvailable from publisher's website |
| 999 |
_c5719152 _d5719152 |
||